Barclays PLC Charles River Laboratories International, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Barclays PLC holds 130,826 shares of CRL stock, worth $24.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

130,826

Previous 130,826 -0.0%

Holding current value

$24.3 Million

Previous $25.8 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$187.96 - $245.29 $6.46 Million - $8.43 Million	-34,379 Reduced 20.81%	130,826 $25.8 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $10.7 Million - $13.9 Million	51,731 Added 45.59%	165,205 $34.1 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $11.3 Million - $15.2 Million	-55,722 Reduced 32.93%	113,474 $30.7 Million
Q4 2023 Feb 15, 2024	SELL	$164.52 - $238.84 $2.99 Million - $4.35 Million	-18,194 Reduced 9.71%	169,196 $40 Million
Q3 2023 Nov 07, 2023	BUY	$194.44 - $217.61 $7.51 Million - $8.4 Million	38,620 Added 25.96%	187,390 $36.7 Million
Q2 2023 Aug 03, 2023	BUY	$183.71 - $210.25 $18.4 Million - $21 Million	99,907 Added 204.46%	148,770 $31.3 Million
Q1 2023 May 04, 2023	SELL	$191.89 - $259.92 $3.44 Million - $4.66 Million	-17,913 Reduced 26.83%	48,863 $9.86 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $986,338 - $1.25 Million	-5,004 Reduced 6.97%	66,776 $14.5 Million
Q3 2022 Nov 03, 2022	SELL	$182.44 - $250.54 $10.4 Million - $14.3 Million	-57,209 Reduced 44.35%	71,780 $14.1 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $3.08 Million - $4.57 Million	15,100 Added 13.26%	128,989 $27.6 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $7.91 Million - $11.2 Million	30,959 Added 37.33%	113,889 $32.3 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $1.96 Million - $2.5 Million	5,569 Added 7.2%	82,930 $31.2 Million
Q3 2021 Nov 09, 2021	BUY	$372.64 - $458.3 $3.69 Million - $4.54 Million	9,915 Added 14.7%	77,361 $31.9 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $16 Million - $20.2 Million	54,480 Added 420.18%	67,446 $24.9 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $2.9 Million - $3.48 Million	11,614 Added 859.02%	12,966 $3.76 Million
Q4 2020 Feb 11, 2021	BUY	$222.0 - $252.62 $300,144 - $341,542	1,352 New	1,352 $338,000
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $82,513 - $106,431	-470 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$118.84 - $189.72 $55,854 - $89,168	470 New	470 $82,000
Q1 2020 May 13, 2020	SELL	$98.9 - $178.34 $830,067 - $1.5 Million	-8,393 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$126.05 - $152.76 $504,200 - $611,040	4,000 Added 91.05%	8,393 $1.28 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $369,957 - $424,975	-2,958 Reduced 40.24%	4,393 $582,000
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $2.78 Million - $3.34 Million	-22,513 Reduced 75.39%	7,351 $1.04 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $1.05 Million - $1.47 Million	-10,011 Reduced 25.11%	29,864 $4.34 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $891,163 - $1.16 Million	8,480 Added 27.01%	39,875 $4.51 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $4.59 Million - $5.51 Million	-40,955 Reduced 56.61%	31,395 $4.23 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $1.86 Million - $2.13 Million	18,128 Added 33.43%	72,350 $8.12 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $3.45 Million - $4.05 Million	35,163 Added 184.5%	54,222 $5.79 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $1.89 Million - $2.22 Million	18,777 Added 6658.51%	19,059 $2.09 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $27,275 - $30,811	282	282 $30,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account